Large EHR study confirms Paxlovid works best within 5-day time window
By
Alicia Lasek
Mar 20, 2023
Protection against severe outcomes soared to 80% when the drug was dispensed within five days of symptom onset, compared with 54% efficacy outside that time frame, investigators found.
Amyloid brain plaques not a sure sign of Alzheimer’s, researchers find
By
Alicia Lasek
Jan 12, 2023
A new study challenges the theory that an increase in brain amyloid protein signals Alzheimer’s disease. The findings may be especially relevant to clinicians as amyloid-targeting drugs such as Leqembi...
CDC: Seniors’ comparative rate of hospitalization spiked during omicron wave
By
Alicia Lasek
Aug 26, 2022
Rates of hospitalization among seniors rose higher in comparison to younger adults during the BA.2 wave, with vaccinations providing less protection, new data show.
Nursing home worker nails down a manicurist gig
By
Foster Stubbs
Apr 05, 2023
Marielle Smith may only be 19 years old, but she has big dreams. Being the daughter of a cosmetologist, one of them is to open her own nail salon. But for now, she has a significant client base at...
Pressure injuries found in 11% of SNF stroke rehab patients: study
By
Alicia Lasek
Aug 08, 2022
Providing early care for pressure injuries during stroke rehab may help improve patients’ clinical outcomes and reduce associated costs, investigators say.
Having My Say | When it feels like content is king, bring in the ‘X’
By
Kimberly Marselas
Jul 01, 2022
Given the chance to question a Washington correspondent for a major broadcast news organization recently, long-term care leaders didn’t drill down on budget reconciliations, Medicare coverage or healthcare...
NY nursing home residents pay homage to Taylor Swift
By
Foster Stubbs
Jun 14, 2023
Estimated to generate $4.6 billion for local economies nationwide, it’s no secret that the hottest tickets of the summer are for Taylor Swift’s The Eras tour. Residents of The Grand Rehabilitation...
First human trial of Pfizer’s bivalent booster finds shot safe, effective
By
Alicia Lasek
Oct 14, 2022
New data from a trial in humans shows that the omicron-adapted COVID-19 booster made by Pfizer and BioNTech is safe and effective in older adults, according to the drugmakers.
Lawmakers push to keep ‘ineffective’ new opioids from market
By
Alicia Lasek
Mar 08, 2023
Congressional lawmakers have renewed efforts to give the Food and Drug Administration more power to deny drug applications for opioids that are not proven clinically superior to and lower risk than currently...
WHO: Some superbugs became more antibiotic resistant during the pandemic
By
Alicia Lasek
Dec 12, 2022
Bacteria that cause healthcare-associated bloodstream infections gained increased resistance to last-resort antibiotics, according to a new report.